The MinION nanopore sequencer was released to community testers for evaluation using a variety of sequencing applications. The MinION was used to evaluate upper respiratory disease infections and was found to have tremendous potential for field use. In this study, we tested the ability of the MinION to accurately identify and differentiate clinical bacterial and viral samples via targeted sequencing and whole genome sequencing. The current nanopore technology has limitations with respect to error rate but has steadily improved with development of new flow cells and library kits.
展开▼
